Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

DVA

DaVita Inc

217.04

Jun 26 • 04:00PM ET +3.68 (1.72%)

Healthcare Medical Care Facilities USA Large NYSE

Peers: FMS THC HCA UHS EHC CHE OPCH ASTH AMN ENSG

| Held by: VTI RSP VOO VB VBR IVV SPY IWP XLV WTV

Scroll to Statements

Index	S&P 500	P/E	20.83	EPS (ttm)	10.42	Insider Own	2.12%	Shs Outstand	66.19M	Perf Week	4.39%
Market Cap	13.93B	Forward P/E	12.56	EPS next Y	17.28	Insider Trans	-69.16%	Shs Float	62.87M	Perf Month	11.35%
Enterprise Value	28.21B	PEG	0.61	EPS next Q	3.84	Inst Own	96.93%	Short Float	7.36%	Perf Quarter	38.45%
Income	756.42M	P/S	1.01	EPS this Y	37.72%	Inst Trans	-4.05%	Short Ratio	5.57	Perf Half Y	89.19%
Sales	13.84B	P/B	-	EPS next Y	16.38%	ROA	4.37%	Short Interest	4.63M	Perf YTD	91.04%
Book/sh	-11.41	P/C	18.61	EPS next 5Y	20.68%	ROE	635.30%	52W High	215.33 0.79%	Perf Year	53.83%
Cash/sh	11.66	P/FCF	9.33	EPS past 3/5Y	18.56% 8.29%	ROIC	6.35%	52W Low	101.00 114.89%	Perf 3Y	123.57%
Dividend Est.	1.67 (0.77%)	EV/EBITDA	10.19	Sales past 3/5Y	5.53% 3.39%	Gross Margin	27.27%	Volatility	2.53% 2.79%	Perf 5Y	78.38%
Dividend TTM	-	EV/Sales	2.04	EPS Y/Y TTM	2.79%	Oper. Margin	14.82%	ATR (14)	5.70	Perf 10Y	186.71%
Dividend Ex-Date	-	Quick Ratio	1.37	Sales Y/Y TTM	6.68%	Profit Margin	5.47%	RSI (14)	74.57	Recom	2.89
Dividend Gr. 3/5Y	- -	Current Ratio	1.42	EPS Q/Q	43.08%	SMA20	7.07%	Beta	0.87	Target Price	200.00
Payout	0.00%	Debt/Eq	-	Sales Q/Q	5.96%	SMA50	16.28%	Rel Volume	1.91	Prev Close	213.36
Employees	78000	LT Debt/Eq	-	Earnings	May 05 AMC	SMA200	50.46%	Avg Volume	830.13K	Price	217.04
IPO	Oct 31, 1995	Option/Short	Yes / Yes	EPS/Sales Surpr.	23.18% 1.76%	Trades		Volume	1,588,805	Change	1.72%

Date	Action	Analyst	Rating Change	Price Target Change
May-06-26	Upgrade	Deutsche Bank	Hold → Buy	$220
Mar-06-24	Initiated	Barclays	Equal Weight	$133
Aug-07-23	Upgrade	UBS	Neutral → Buy	$100 → $142
Nov-01-22	Downgrade	Deutsche Bank	Buy → Hold	$97 → $72
Oct-31-22	Downgrade	UBS	Buy → Neutral	$117 → $74
Aug-19-22	Resumed	UBS	Buy	$106 → $117
Jun-21-22	Reiterated	BofA Securities	Underperform	$110 → $90
Sep-10-21	Initiated	Cowen	Market Perform	$145
Aug-12-21	Downgrade	Barclays	Overweight → Equal Weight	$135 → $146
Mar-26-21	Downgrade	BofA Securities	Neutral → Underperform	$127 → $118
Jan-05-21	Downgrade	BofA Securities	Buy → Neutral	$127
Jan-24-20	Upgrade	Goldman	Neutral → Buy	$72 → $97
Nov-07-19	Downgrade	Raymond James	Outperform → Mkt Perform
Oct-25-19	Downgrade	Wolfe Research	Outperform → Peer Perform
Sep-11-19	Downgrade	William Blair	Outperform → Mkt Perform
Jul-26-19	Downgrade	Robert W. Baird	Outperform → Neutral	$70 → $65
Jan-08-19	Upgrade	UBS	Sell → Neutral
Jan-03-19	Initiated	Deutsche Bank	Buy	$60
Dec-14-18	Initiated	Barclays	Overweight
Nov-28-18	Upgrade	Raymond James	Mkt Perform → Outperform

Show Previous Ratings

May-18-26 03:00PM	DaVita Sets Bold 2030 Community Care Commitments After Exceeding Prior Five-Year ESG Goals (PR Newswire)
May-12-26 10:41AM	Rosarium Health Raises $6M In Seed Funding Round To Provide Reliable And Faster In-Home Care For Aging Populations (AfroTech)
May-06-26 06:01PM	DaVita Inc. to Participate in the BofA Securities 2026 Health Care Conference (PR Newswire) +23.46%
May-05-26 04:05PM	DaVita Inc. 1st Quarter 2026 Results (PR Newswire)
Apr-20-26 02:06PM	DaVita Inc. Schedules 1st Quarter 2026 Investor Conference Call (PR Newswire)
08:06PM	Loading…
Mar-31-26 08:06PM	Should Value Investors Buy DaVita (DVA) Stock? (Quartz)
Mar-18-26 03:00PM	DaVita Highlights Continued Progress in Value-Based Kidney Care as CKCC Results Show Year-Over-Year Improvement (PR Newswire)
Mar-06-26 11:49AM	Here's Why You Should Add DaVita Stock to Your Portfolio for Now (Zacks)
Mar-05-26 12:40PM	Is DaVita Inc. (DVA) A Good Stock To Buy? (Insider Monkey)
Mar-04-26 11:30AM	DaVita HealthCare (DVA) Up 13% Since Last Earnings Report: Can It Continue? (Zacks)
10:08AM	Jim Cramer on DaVita: "Haven't Seen That Stock Do That Well In This Long" (Insider Monkey)
Mar-03-26 06:56PM	How Berkshire Hathaway Performed During Buffett's Final Quarter (MarketBeat)
Feb-27-26 04:48AM	New Strong Buy Stocks for February 27th (Zacks)
04:03AM	Best Value Stocks to Buy for February 27th (Zacks)
03:50AM	Best Growth Stocks to Buy for February 27th (Zacks)
02:00PM	Loading…
Feb-24-26 02:00PM	DaVita Inc. to Participate in TD Cowen's 46th Annual Health Care Conference (PR Newswire)
09:40AM	Here's Why DaVita HealthCare (DVA) is a Strong Value Stock (Zacks)
02:53AM	Best Value Stocks to Buy for February 24th (Zacks)
Feb-23-26 09:40AM	Is DaVita (DVA) Stock Undervalued Right Now? (Zacks)
Feb-20-26 09:50AM	Why DaVita HealthCare (DVA) is a Top Momentum Stock for the Long-Term (Zacks)
04:09AM	Zacks.com featured highlights include DaVita, Ford, Centerra, Southwest Airlines and Patria Investments (Zacks)
Feb-19-26 09:20AM	5 Value Stocks to Buy Now as Fed Debates Next Rate Move (Zacks)
05:30AM	New Strong Buy Stocks for February 19th (Zacks)
04:34AM	Best Value Stocks to Buy for February 19th (Zacks)
Feb-17-26 04:53PM	Buffett's Final Filing: Berkshire Initiates New York Times Stake, Slashes Amazon Position Before CEO Transition (Benzinga)
Feb-13-26 10:24AM	PacBio Q4 Earnings and Revenues Beat Estimates, Gross Margin Up (Zacks)
Feb-12-26 11:03AM	BAX Stock Falls Following Q4 Earnings Miss, Margins Contract (Zacks)
10:54AM	INSP Stock Falls Despite Q4 Earnings Beat, Gross Margin Expands (Zacks)
10:41AM	AVTR Stock Plunges Despite Q4 Earnings Beat Estimates, Margins Decline (Zacks)
09:25AM	QuidelOrtho Q4 Earnings and Revenues Beat Estimates, Margins Down (Zacks)
09:15AM	Loading…
Feb-11-26 09:15AM	Quest Diagnostics Incorporated (DGX) Hit a 52 Week High, Can the Run Continue? (Zacks)
Feb-10-26 12:30PM	ECL Stock Falls in Pre-Market Despite Q4 Earnings Beat, Margins Expand (Zacks)
09:32AM	4 Discounted PEG Value Stocks to Boost Your Portfolio's Health (Zacks)
Feb-09-26 10:38AM	BD Stock Dips in Pre-Market Despite Q1 Earnings Beat, Margins Up (Zacks)
08:50AM	DaVita Stock: Is Wall Street Bullish or Bearish? (Barchart)
12:31AM	The 5 Most Interesting Analyst Questions From DaVita's Q4 Earnings Call (StockStory)
Feb-05-26 09:40AM	Should Value Investors Buy DaVita (DVA) Stock? (Zacks) +5.04%
09:40AM	Why DaVita HealthCare (DVA) is a Top Value Stock for the Long-Term (Zacks)
Feb-04-26 07:55PM	Analyst Report: DaVita Inc. (Morningstar Research) +5.44%
02:54PM	3 Warren Buffett-Style Stocks for a Golden Retirement (24/7 Wall St.)
10:59AM	DaVita (DVA) Q1 2025 Earnings Call Transcript (Motley Fool)
Feb-03-26 06:03PM	Stocks to Watch Tuesday Recap: PayPal, PepsiCo, AMD, Disney (The Wall Street Journal) +21.17%
04:26PM	Stocks Tumble on AI Disruption Fears (Barchart)
01:18PM	Stocks Fall, Gold Rallies On Best Day Since 2008: What's Moving Markets Tuesday? (Benzinga)
12:38PM	What Sent DaVita Stock Soaring On Tuesday? (Motley Fool)
12:25PM	DaVita Stock Rallies On Profit Beat, Confident 2026 View (Benzinga)
11:45AM	Why Is DaVita (DVA) Stock Rocketing Higher Today (StockStory)
11:16AM	This Berkshire Hathaway Holding Is Up 25%. Earnings Breeze Past Estimates. (Barrons.com)
11:14AM	Software Stocks Retreat and Drag the Broader Market Lower (Barchart)
10:23AM	DaVita Stock Up Following Q4 Earnings & Revenue Beat, Margins Expand (Zacks)
09:59AM	Nasdaq Slips, Gold and Silver Stage Substantial Recovery (Barchart)
09:40AM	Stocks to Watch Tuesday: PayPal, PepsiCo, AMD, Disney (The Wall Street Journal)
08:10AM	DVA Q4 Deep Dive: Clinical Initiatives and Integrated Care Drive Outlook Amid Margin Compression (StockStory)
05:54AM	Teradyne's 'blowout' guidance sees stock surge, and other early movers (MarketWatch)
12:01AM	DaVita Inc (DVA) Q4 2025 Earnings Call Highlights: Strong Financial Performance Amid Challenges (GuruFocus.com)
Feb-02-26 09:55PM	Analyst Report: DaVita Inc. (Morningstar Research)
08:40PM	DaVita Inc. (DVA): A Bull Case Theory (Insider Monkey)
06:38PM	DaVita Q4 Earnings Call Highlights (MarketBeat)
05:20PM	DaVita HealthCare (DVA) Q4 Earnings and Revenues Surpass Estimates (Zacks)
04:20PM	DaVita (NYSE:DVA) Beats Expectations in Strong Q4 CY2025, Stock Soars (StockStory)
04:05PM	DaVita Inc. 4th Quarter 2025 Results (PR Newswire)
03:00PM	Elara Caring Secures New Strategic Investment from Ares and DaVita (Business Wire)
Jan-31-26 10:01PM	DaVita (DVA) Q4 Earnings: What To Expect (StockStory)
Jan-30-26 11:56AM	Can Operational Execution Support DaVita's Q4 Performance? (Zacks)
Jan-29-26 11:34PM	3 Healthcare Stocks We Steer Clear Of (StockStory)
Jan-27-26 06:00PM	DaVita HealthCare (DVA) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
Jan-21-26 06:15PM	DaVita HealthCare (DVA) Outperforms Broader Market: What You Need to Know (Zacks)
10:00AM	DaVita Inc. Schedules 4th Quarter 2025 Investor Conference Call (PR Newswire)
Jan-19-26 12:31PM	Here's Why You Should Hold DaVita Stock in Your Portfolio for Now (Zacks)
Jan-16-26 01:56PM	Hedge Funds Are Shorting This Classic Warren Buffett Stock. Should You Sell Shares Now? (Barchart)
04:25AM	DaVita - In the sweet spot of Growth and Value (GuruFocus.com)
Jan-15-26 10:34AM	Here's What to Expect From DaVita's Next Earnings Report (Barchart)
Jan-14-26 11:50AM	Behind Berkshires Curtain: Is Greg Abel Preparing to Cut Davita Loose? (Barchart)
Jan-13-26 06:00PM	DaVita HealthCare (DVA) Suffers a Larger Drop Than the General Market: Key Insights (Zacks) -5.11%
Jan-07-26 06:00PM	Why DaVita HealthCare (DVA) Dipped More Than Broader Market Today (Zacks)
06:00AM	What Is the Plan for Berkshire Hathaway's $300 Billion Equity Portfolio Following Warren Buffett's Retirement? (Motley Fool)
Jan-02-26 09:32AM	Warren Buffetts Likely Replacement as Berkshires Top Stock Picker Has a Lot to Prove (Barrons.com)
Dec-29-25 08:53AM	Meet the New Berkshire, Same as the Old Berkshire (Barrons.com)
01:30AM	Berkshire's Buffett Is Stepping Down. Why Little Will Change and Why That's OK. (Barrons.com)
Dec-23-25 09:02AM	Buffetts $24 Billion Selling Spree: The 6 Stocks Berkshire Hathaway Dumped (24/7 Wall St.)
Dec-22-25 06:00PM	DaVita HealthCare (DVA) Beats Stock Market Upswing: What Investors Need to Know (Zacks)
09:14AM	Zacks Industry Outlook Highlights Encompass Health, DaVita, Option Care Health and The Pennant (Zacks)
Dec-19-25 09:13AM	4 Outpatient Home Health Stocks in Focus as Market Dynamics Change (Zacks)
Dec-18-25 09:07AM	Here's Why You Should Hold DaVita Stock in Your Portfolio for Now (Zacks)
Dec-15-25 09:05AM	Is DaVita Stock Underperforming the Dow? (Barchart)
Dec-11-25 08:00AM	DaVita Names New Leaders to Accelerate Care Transformation (PR Newswire)
Nov-28-25 11:30AM	Why Is DaVita HealthCare (DVA) Up 1.1% Since Last Earnings Report? (Zacks)
Nov-24-25 11:49AM	Alphabet Stock Is a Berkshire Win. The Gain So Far May Be 40%. (Barrons.com)
Nov-14-25 04:53PM	Barcharts Technical Indicators Are Flashing Buy as Warren Buffett Loads Up on 17.8 Million Shares of Google Stock (Barchart)
04:16PM	DaVita Inc. to Participate in Fireside Chat with Wolfe Research (PR Newswire)
Nov-13-25 10:31PM	Unpacking Q3 Earnings: DaVita (NYSE:DVA) In The Context Of Other Outpatient & Specialty Care Stocks (StockStory)
Nov-12-25 01:11PM	Jim Cramer Discusses DaVita's (DVA) Share Price Movement (Insider Monkey)
Nov-10-25 06:41AM	DaVita Stock: Analyst Estimates & Ratings (Barchart)
Nov-05-25 12:38AM	DaVita's Q3 Earnings Call: Our Top 5 Analyst Questions (StockStory)
Nov-04-25 08:00AM	DaVita Marks 25 Years of Innovation with Breakthrough Kidney Care Research at ASN Kidney Week 2025 (PR Newswire)
Nov-02-25 01:07PM	3 Warren Buffett Stocks to Buy Hand Over Fist in November (Motley Fool)
Oct-30-25 07:39PM	Analyst Report: DaVita Inc. (Morningstar Research) -6.17%
01:59PM	DaVita Stock Down Post Q3 Earnings Miss Estimates, Revenues Up Y/Y (Zacks)
01:35AM	DVA Q3 2025 Deep Dive: Lower Volumes and Margin Compression Shape Outlook Amid Industry Uncertainty (StockStory)
Oct-29-25 05:25PM	DaVita (NYSE:DVA) Reports Q3 In Line With Expectations (StockStory)

DaVita, Inc. engages in the provision of medical care services. It operates through the US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives segments. The US Dialysis and Related Lab Services segment offer kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consists primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.

CEO & Executive DirectorMr. Javier J. Rodriguez

CFO & TreasurerMr. Joel Ackerman

Chief Legal & Public Affairs OfficerMs. Kathleen Alyce Waters

Chief Compliance OfficerMr. James O. Hearty

Chief Operating Officer of DaVita Kidney CareMr. David P. Maughan

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Waters Kathleen Alyce	Chief Legal & Pub. Affairs Off	Jun 15 '26	Sale	208.40	15,405	3,210,377	109,194	Jun 17 06:10 PM
Rodriguez Javier	Chief Executive Officer	Jun 16 '26	Sale	209.28	39,407	8,247,018	840,408	Jun 17 06:09 PM
Rodriguez Javier	Chief Executive Officer	Jun 15 '26	Sale	209.50	30,000	6,285,090	879,815	Jun 17 06:09 PM
Javier Rodgriguez	Officer	Jun 16 '26	Proposed Sale	209.28	39,407	8,247,016		Jun 16 04:44 PM
Kathleen Waters	Officer	Jun 15 '26	Proposed Sale	207.84	8,950	1,860,202		Jun 15 04:53 PM
Javier Rodriguez	Officer	Jun 15 '26	Proposed Sale	209.50	30,000	6,285,102		Jun 15 04:48 PM
Waters Kathleen Alyce	Officer	Jun 15 '26	Proposed Sale	207.93	6,455	1,342,188		Jun 15 04:10 PM
HEARTY JAMES O	Chief Compliance Officer	May 14 '26	Option Exercise	110.63	5,784	639,884	41,737	May 18 04:08 PM
HEARTY JAMES O	Chief Compliance Officer	May 15 '26	Sale	193.98	15,000	2,909,745	22,389	May 18 04:08 PM
James Hearty	Officer	May 15 '26	Proposed Sale	193.93	15,000	2,908,950		May 15 03:12 PM
Maughan David Paul	Chief Operating Officer, DKC	May 12 '26	Sale	199.25	13,456	2,681,162	94,105	May 13 04:10 PM
Maughan David Paul	Chief Operating Officer, DKC	May 11 '26	Sale	199.15	7,073	1,408,581	107,561	May 13 04:10 PM
David Maughan	Officer	May 11 '26	Proposed Sale	198.03	20,529	4,065,340		May 11 05:40 PM
ACKERMAN JOEL	CFO and Treasurer	May 07 '26	Sale	192.10	51,471	9,887,528	132,434	May 11 04:05 PM
HEARTY JAMES O	Chief Compliance Officer	May 06 '26	Sale	174.87	2,184	381,916	35,953	May 08 04:04 PM
Joel Ackerman	Officer	May 07 '26	Proposed Sale	191.50	51,471	9,856,696		May 07 04:43 PM
HEARTY JAMES O	Officer	May 06 '26	Proposed Sale	169.28	2,184	369,708		May 06 04:03 PM
BERKSHIRE HATHAWAY INC	10% Owner	May 01 '26	Sale	149.84	1,220,376	182,864,679	28,880,209	May 05 06:52 PM
Waters Kathleen Alyce	Chief Legal & Pub. Affairs Off	Feb 06 '26	Option Exercise	108.93	8,079	880,045	105,833	Feb 09 06:57 PM
ACKERMAN JOEL	CFO and Treasuer	Feb 06 '26	Option Exercise	108.93	44,065	4,800,000	185,705	Feb 09 06:56 PM
BERKSHIRE HATHAWAY INC	10% Owner	Jan 29 '26	Sale	120.56	1,658,480	199,939,881	30,100,585	Feb 02 05:30 PM
HEARTY JAMES O	Chief Compliance Officer	Dec 04 '25	Option Exercise	108.93	5,875	639,964	31,913	Dec 05 04:35 PM
BERKSHIRE HATHAWAY INC	10% Owner	Oct 27 '25	Sale	135.36	401,514	54,347,249	31,759,065	Oct 29 06:09 PM
BERKSHIRE HATHAWAY INC	10% Owner	Jul 31 '25	Sale	140.61	1,635,962	230,024,764	32,160,579	Aug 04 09:00 PM
HEARTY JAMES O	Chief Compliance Officer	Jul 23 '25	Sale	150.00	2,351	352,650	26,038	Jul 24 08:34 PM
HEARTY JAMES O	Officer	Jul 23 '25	Proposed Sale	150.00	2,351	352,650		Jul 23 04:05 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

DVA

DaVita Inc

Upgrade your Finviz experience